PMID- 12688625 OWN - NLM STAT- MEDLINE DCOM- 20030515 LR - 20191107 IS - 0905-6157 (Print) IS - 0905-6157 (Linking) VI - 13 IP - s15 DP - 2002 TI - Study on the prevention of allergy in Children in Europe (SPACE): allergic sensitization in children at 1 year of age in a controlled trial of allergen avoidance from birth. PG - 47-54 AB - Several studies have demonstrated that early intervention may modulate the natural course of atopic disease. Our objective was to prevent sensitization to house-dust mite and food allergens, as well as the development of atopic symptoms during infancy, by the combination of an educational package and the use of mite allergen-impermeable mattress encasings. A multicentre European, population-based, randomized, controlled study of children at increased atopic risk [Study on the Prevention of Allergy in Children in Europe (SPACE)] was performed in five countries (Austria, Germany, Greece, the UK, and Lithuania), and included three cohorts - schoolchildren, toddlers, and newborns. We report on the newborn cohort. A total of 696 newborns were included from Austria, the UK, and Germany. Inclusion criteria were: a positive history of parental allergy; and a positive skin-prick test or specific immunoglobulin E (IgE) (IgE > or = 1.43 kU/L) against at least one out of a panel of common aeroallergens in one or both parents. At 1 year of age, the overall sensitization rate against the tested allergens [dust-mite allergens: Dermatophagoides pteronyssinus and Dermatophagoides farinae (Der p and Der f)] and food allergens (egg, milk) in the prophylactic group was 6.21% vs. 10.67% in the control group. The prevalence of sensitization against Der p was 1.86% in the prophylactic group vs. 5% in the control group. In conclusion, we were able to demonstrate, in a group of newborns at risk for atopic diseases, that the sensitization rate to a panel of aero- and food allergens could be effectively decreased through the use of impermeable mattress encasings and the implementation of easy-to-perform preventive measures. FAU - Halmerbauer, Gerhard AU - Halmerbauer G AD - University Children's Hospital, Vienna, Austria. FAU - Gartner, Christian AU - Gartner C FAU - Schier, Michael AU - Schier M FAU - Arshad, Hassan AU - Arshad H FAU - Dean, Tara AU - Dean T FAU - Koller, Dieter Y AU - Koller DY FAU - Karmaus, Wilfried AU - Karmaus W FAU - Kuehr, Joachim AU - Kuehr J FAU - Forster, Johannes AU - Forster J FAU - Urbanek, Radvan AU - Urbanek R FAU - Frischer, Thomas AU - Frischer T CN - SPACE collaborative study team LA - eng PT - Clinical Trial PT - Comparative Study PT - Journal Article PT - Multicenter Study PT - Randomized Controlled Trial PT - Research Support, Non-U.S. Gov't PL - England TA - Pediatr Allergy Immunol JT - Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology JID - 9106718 RN - 0 (Allergens) RN - 0 (Antigens, Dermatophagoides) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Allergens/adverse effects/immunology MH - Antibody Specificity/immunology MH - Antigens, Dermatophagoides/adverse effects/immunology MH - Europe/epidemiology MH - Floors and Floorcoverings MH - Follow-Up Studies MH - Humans MH - Hypersensitivity, Immediate/epidemiology/immunology/*prevention & control MH - Immunization MH - Immunoglobulin E/blood/immunology MH - Incidence MH - Infant Welfare MH - Infant, Newborn MH - Prospective Studies MH - Risk Reduction Behavior MH - Surveys and Questionnaires EDAT- 2003/04/12 05:00 MHDA- 2003/05/16 05:00 CRDT- 2003/04/12 05:00 PHST- 2003/04/12 05:00 [pubmed] PHST- 2003/05/16 05:00 [medline] PHST- 2003/04/12 05:00 [entrez] AID - 10.1034/j.1399-3038.13.s.15.11.x [doi] PST - ppublish SO - Pediatr Allergy Immunol. 2002;13(s15):47-54. doi: 10.1034/j.1399-3038.13.s.15.11.x.